Appointment booking for Dr. Michael Duffin, MD is currently not available.Dr. Michael Duffin, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Duffin, MD (he/him) is a Rheumatologist in Torrance, CA with over 18 years of experience. What is your opinion of Dr. Michael Duffin, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Duffin, MD has received over $6,735 which includes payments from the following companies:
$1,054.78 from AbbVie, Inc.
$992.82 from Janssen Biotech, Inc.
$858.56 from Pfizer Inc.
$754.99 from Celgene Corporation
$709.84 from Amgen Inc.
$346.18 from Genentech USA, Inc.
$279.95 from Novartis Pharmaceuticals Corporation
$256.54 from Horizon Pharma plc
$244.68 from sanofi-aventis U.S. LLC
$114.54 from UCB, Inc.
$104.77 from Crealta Pharmaceuticals LLC
$101.89 from Purdue Pharma L.P.
$92.98 from LILLY USA, LLC
$92.56 from Flexion Therapeutics, Inc.
$87.72 from E.R. Squibb & Sons, L.L.C.
$66.19 from GlaxoSmithKline, LLC.
$62.61 from Zogenix Inc.
$56.94 from Questcor Pharmaceuticals
$54.20 from Antares Pharma, Inc.
$46.48 from AstraZeneca Pharmaceuticals LP
Payments received by Dr. Michael Duffin, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!